Committed to the future
Our technology-driven drug discovery delivers breakthroughs
We work in an unbroken chain — from research and discovery, through development and commercialization — to surmount the challenges of innovating in new frontiers.
Breakthrough history
Our commitment to delivering breakthroughs has produced an exciting portfolio of medicines that have the potential to change treatment paradigms and understanding of diseases.
Over the years, our portfolio has drawn from expertise in antibody engineering, fermentation technology, and manufacturing to advance new medicines to market. See more about our history here.
We continue to build on Kyowa Kirin’s rich history of innovation through new clinical programs , strategic partnerships, and by engaging with the medical and patient communities we serve.
Immunology
Our expertise in antibody discovery and development has fueled new patents, development programs, and the creation of effective medicines for patients. It also has been at the forefront of key industry advancements, including the ability to safely and reliably reproduce fully human monoclonal antibodies that precisely eliminate target cells that cause disease. Learn more here.
Technology-driven drug discovery
We find inspiration for new drug discoveries in all stages of research, development, and commercialization. Our research team is working to engineer the next generation of antibodies and cell and gene therapies, with the potential to deliver life-changing value to patients in our therapeutic areas of focus: bone and mineral, intractable hematologic diseases/hemaoto oncology, and rare diseases. In La Jolla, our lab has deep expertise and a proud legacy of discovering and engineering therapeutic antibodies. We also believe in the value of strategic collaborations to advance new discoveries.
